ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leber Congenital Amaurosis (LCA) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-24W5730
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Leber Congenital Amaurosis LCA Market Insights Forecast to 2028
BUY CHAPTERS

Global Leber Congenital Amaurosis (LCA) Market Insights, Forecast to 2030

Code: QYRE-Auto-24W5730
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AmpliPhi Biosciences
Editas Medicine
Novelion Therapeutics
ProQR Therapeutics
Spark Therapeutics

Leber Congenital Amaurosis (LCA) Market

Leber congenital amaurosis is a kind of autosomal recessive genetic disease, it is the main genetic disease that brings about children blindness, accompany mental nerve symptom, wait like intellectual inferior, hearing obstacle, epilepsy, conus cornea can happen when some age is older or spherical cornea.
Market Analysis and Insights: Global Leber Congenital Amaurosis (LCA) Market
The global Leber Congenital Amaurosis (LCA) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Leber Congenital Amaurosis (LCA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Leber Congenital Amaurosis (LCA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Leber Congenital Amaurosis (LCA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Leber Congenital Amaurosis (LCA) include AmpliPhi Biosciences, Editas Medicine, Novelion Therapeutics, ProQR Therapeutics and Spark Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Leber Congenital Amaurosis (LCA) is widely used in various fields, such as Hospitals, Eye Clinics, Medical Research Institute and Other, etc. Hospitals provides greatest supports to the Leber Congenital Amaurosis (LCA) industry development. In 2023, global % revenue of Leber Congenital Amaurosis (LCA) went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Leber Congenital Amaurosis (LCA) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leber Congenital Amaurosis (LCA), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Leber Congenital Amaurosis (LCA), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leber Congenital Amaurosis (LCA) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Leber Congenital Amaurosis (LCA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Leber Congenital Amaurosis (LCA) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Leber Congenital Amaurosis (LCA) Market Report

Report Metric Details
Report Name Leber Congenital Amaurosis (LCA) Market
Segment by Type
  • Infantile Type
  • Juvenile Type
Segment by Application
  • Hospitals
  • Eye Clinics
  • Medical Research Institute
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AmpliPhi Biosciences, Editas Medicine, Novelion Therapeutics, ProQR Therapeutics, Spark Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Leber Congenital Amaurosis (LCA) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Leber Congenital Amaurosis (LCA) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leber Congenital Amaurosis (LCA) revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Leber Congenital Amaurosis (LCA) Market report?

Ans: The main players in the Leber Congenital Amaurosis (LCA) Market are AmpliPhi Biosciences, Editas Medicine, Novelion Therapeutics, ProQR Therapeutics, Spark Therapeutics

What are the Application segmentation covered in the Leber Congenital Amaurosis (LCA) Market report?

Ans: The Applications covered in the Leber Congenital Amaurosis (LCA) Market report are Hospitals, Eye Clinics, Medical Research Institute, Other

What are the Type segmentation covered in the Leber Congenital Amaurosis (LCA) Market report?

Ans: The Types covered in the Leber Congenital Amaurosis (LCA) Market report are Infantile Type, Juvenile Type

Recommended Reports

Ophthalmic Disease Treatments

Retinal Disorders

Genetic & Rare Diseases

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Infantile Type
1.2.3 Juvenile Type
1.3 Market by Application
1.3.1 Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leber Congenital Amaurosis (LCA) Market Perspective (2019-2030)
2.2 Global Leber Congenital Amaurosis (LCA) Growth Trends by Region
2.2.1 Leber Congenital Amaurosis (LCA) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Leber Congenital Amaurosis (LCA) Historic Market Size by Region (2019-2024)
2.2.3 Leber Congenital Amaurosis (LCA) Forecasted Market Size by Region (2025-2030)
2.3 Leber Congenital Amaurosis (LCA) Market Dynamics
2.3.1 Leber Congenital Amaurosis (LCA) Industry Trends
2.3.2 Leber Congenital Amaurosis (LCA) Market Drivers
2.3.3 Leber Congenital Amaurosis (LCA) Market Challenges
2.3.4 Leber Congenital Amaurosis (LCA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Leber Congenital Amaurosis (LCA) by Players
3.1.1 Global Leber Congenital Amaurosis (LCA) Revenue by Players (2019-2024)
3.1.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Players (2019-2024)
3.2 Global Leber Congenital Amaurosis (LCA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Leber Congenital Amaurosis (LCA), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Leber Congenital Amaurosis (LCA) Market Concentration Ratio
3.4.1 Global Leber Congenital Amaurosis (LCA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leber Congenital Amaurosis (LCA) Revenue in 2023
3.5 Global Key Players of Leber Congenital Amaurosis (LCA) Head office and Area Served
3.6 Global Key Players of Leber Congenital Amaurosis (LCA), Product and Application
3.7 Global Key Players of Leber Congenital Amaurosis (LCA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leber Congenital Amaurosis (LCA) Breakdown Data by Type
4.1 Global Leber Congenital Amaurosis (LCA) Historic Market Size by Type (2019-2024)
4.2 Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Type (2025-2030)
5 Leber Congenital Amaurosis (LCA) Breakdown Data by Application
5.1 Global Leber Congenital Amaurosis (LCA) Historic Market Size by Application (2019-2024)
5.2 Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Leber Congenital Amaurosis (LCA) Market Size (2019-2030)
6.2 North America Leber Congenital Amaurosis (LCA) Market Size by Type
6.2.1 North America Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024)
6.2.2 North America Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030)
6.2.3 North America Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
6.3 North America Leber Congenital Amaurosis (LCA) Market Size by Application
6.3.1 North America Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024)
6.3.2 North America Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030)
6.3.3 North America Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
6.4 North America Leber Congenital Amaurosis (LCA) Market Size by Country
6.4.1 North America Leber Congenital Amaurosis (LCA) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024)
6.4.3 North America Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Leber Congenital Amaurosis (LCA) Market Size (2019-2030)
7.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type
7.2.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024)
7.2.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030)
7.2.3 Europe Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
7.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Application
7.3.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024)
7.3.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030)
7.3.3 Europe Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
7.4 Europe Leber Congenital Amaurosis (LCA) Market Size by Country
7.4.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024)
7.4.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Leber Congenital Amaurosis (LCA) Market Size (2019-2030)
8.2 China Leber Congenital Amaurosis (LCA) Market Size by Type
8.2.1 China Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024)
8.2.2 China Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030)
8.2.3 China Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
8.3 China Leber Congenital Amaurosis (LCA) Market Size by Application
8.3.1 China Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024)
8.3.2 China Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030)
8.3.3 China Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Leber Congenital Amaurosis (LCA) Market Size (2019-2030)
9.2 Asia Leber Congenital Amaurosis (LCA) Market Size by Type
9.2.1 Asia Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024)
9.2.2 Asia Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030)
9.2.3 Asia Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
9.3 Asia Leber Congenital Amaurosis (LCA) Market Size by Application
9.3.1 Asia Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024)
9.3.2 Asia Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030)
9.3.3 Asia Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
9.4 Asia Leber Congenital Amaurosis (LCA) Market Size by Region
9.4.1 Asia Leber Congenital Amaurosis (LCA) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Leber Congenital Amaurosis (LCA) Market Size by Region (2019-2024)
9.4.3 Asia Leber Congenital Amaurosis (LCA) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AmpliPhi Biosciences
11.1.1 AmpliPhi Biosciences Company Details
11.1.2 AmpliPhi Biosciences Business Overview
11.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Introduction
11.1.4 AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024)
11.1.5 AmpliPhi Biosciences Recent Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Introduction
11.2.4 Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024)
11.2.5 Editas Medicine Recent Developments
11.3 Novelion Therapeutics
11.3.1 Novelion Therapeutics Company Details
11.3.2 Novelion Therapeutics Business Overview
11.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.3.4 Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024)
11.3.5 Novelion Therapeutics Recent Developments
11.4 ProQR Therapeutics
11.4.1 ProQR Therapeutics Company Details
11.4.2 ProQR Therapeutics Business Overview
11.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.4.4 ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024)
11.4.5 ProQR Therapeutics Recent Developments
11.5 Spark Therapeutics
11.5.1 Spark Therapeutics Company Details
11.5.2 Spark Therapeutics Business Overview
11.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.5.4 Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024)
11.5.5 Spark Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AmpliPhi Biosciences
Editas Medicine
Novelion Therapeutics
ProQR Therapeutics
Spark Therapeutics
List of Tables
    Table 1. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Infantile Type
    Table 3. Key Players of Juvenile Type
    Table 4. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Leber Congenital Amaurosis (LCA) Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Leber Congenital Amaurosis (LCA) Market Share by Region (2019-2024)
    Table 8. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Leber Congenital Amaurosis (LCA) Market Share by Region (2025-2030)
    Table 10. Leber Congenital Amaurosis (LCA) Market Trends
    Table 11. Leber Congenital Amaurosis (LCA) Market Drivers
    Table 12. Leber Congenital Amaurosis (LCA) Market Challenges
    Table 13. Leber Congenital Amaurosis (LCA) Market Restraints
    Table 14. Global Leber Congenital Amaurosis (LCA) Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Leber Congenital Amaurosis (LCA) Revenue Share by Players (2019-2024)
    Table 16. Global Top Leber Congenital Amaurosis (LCA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber Congenital Amaurosis (LCA) as of 2023)
    Table 17. Global Leber Congenital Amaurosis (LCA) Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Leber Congenital Amaurosis (LCA) Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Leber Congenital Amaurosis (LCA), Headquarters and Area Served
    Table 20. Global Key Players of Leber Congenital Amaurosis (LCA), Product and Application
    Table 21. Global Key Players of Leber Congenital Amaurosis (LCA), Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2019-2024)
    Table 25. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2025-2030)
    Table 27. Global Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Leber Congenital Amaurosis (LCA) Revenue Share by Application (2019-2024)
    Table 29. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Leber Congenital Amaurosis (LCA) Revenue Share by Application (2025-2030)
    Table 31. North America Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Leber Congenital Amaurosis (LCA) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Leber Congenital Amaurosis (LCA) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Leber Congenital Amaurosis (LCA) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Leber Congenital Amaurosis (LCA) Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Leber Congenital Amaurosis (LCA) Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2025-2030) & (US$ Million)
    Table 63. AmpliPhi Biosciences Company Details
    Table 64. AmpliPhi Biosciences Business Overview
    Table 65. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product
    Table 66. AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024) & (US$ Million)
    Table 67. AmpliPhi Biosciences Recent Developments
    Table 68. Editas Medicine Company Details
    Table 69. Editas Medicine Business Overview
    Table 70. Editas Medicine Leber Congenital Amaurosis (LCA) Product
    Table 71. Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024) & (US$ Million)
    Table 72. Editas Medicine Recent Developments
    Table 73. Novelion Therapeutics Company Details
    Table 74. Novelion Therapeutics Business Overview
    Table 75. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 76. Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024) & (US$ Million)
    Table 77. Novelion Therapeutics Recent Developments
    Table 78. ProQR Therapeutics Company Details
    Table 79. ProQR Therapeutics Business Overview
    Table 80. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 81. ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024) & (US$ Million)
    Table 82. ProQR Therapeutics Recent Developments
    Table 83. Spark Therapeutics Company Details
    Table 84. Spark Therapeutics Business Overview
    Table 85. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product
    Table 86. Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2019-2024) & (US$ Million)
    Table 87. Spark Therapeutics Recent Developments
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Leber Congenital Amaurosis (LCA) Market Share by Type: 2023 VS 2030
    Figure 3. Infantile Type Features
    Figure 4. Juvenile Type Features
    Figure 5. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Leber Congenital Amaurosis (LCA) Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Eye Clinics Case Studies
    Figure 9. Medical Research Institute Case Studies
    Figure 10. Other Case Studies
    Figure 11. Leber Congenital Amaurosis (LCA) Report Years Considered
    Figure 12. Global Leber Congenital Amaurosis (LCA) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Leber Congenital Amaurosis (LCA) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Leber Congenital Amaurosis (LCA) Market Share by Region: 2023 VS 2030
    Figure 15. Global Leber Congenital Amaurosis (LCA) Market Share by Players in 2023
    Figure 16. Global Top Leber Congenital Amaurosis (LCA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber Congenital Amaurosis (LCA) as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Leber Congenital Amaurosis (LCA) Revenue in 2023
    Figure 18. North America Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
    Figure 20. North America Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
    Figure 21. North America Leber Congenital Amaurosis (LCA) Market Share by Country (2019-2030)
    Figure 22. United States Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Leber Congenital Amaurosis (LCA) Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
    Figure 26. Europe Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
    Figure 27. Europe Leber Congenital Amaurosis (LCA) Market Share by Country (2019-2030)
    Figure 28. Germany Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Leber Congenital Amaurosis (LCA) Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
    Figure 36. China Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
    Figure 37. Asia Leber Congenital Amaurosis (LCA) Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
    Figure 39. Asia Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
    Figure 40. Asia Leber Congenital Amaurosis (LCA) Market Share by Region (2019-2030)
    Figure 41. Japan Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Leber Congenital Amaurosis (LCA) Market Share by Country (2019-2030)
    Figure 51. Brazil Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. AmpliPhi Biosciences Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2019-2024)
    Figure 58. Editas Medicine Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2019-2024)
    Figure 59. Novelion Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2019-2024)
    Figure 60. ProQR Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2019-2024)
    Figure 61. Spark Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Albinism Drug Market Insights Forecast to 2030
Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2030
Global Ophthalmology Disorders Drug Market Insights Forecast to 2030
Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024
Global Ocular Genetic Diagnostic Market Research Report 2025
Adrenoleukodystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Low Vision Electronic Visual Aids Market Insights Forecast to 2030
Global Amyotrophic Lateral Sclerosis ALS Market Insights Forecast to 2030
Global Low Vision Aids Market Insights Forecast to 2030
Global Metachromatic Leukodystrophy Treatment Market Research Report 2025
Choroideremia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Congenital Heart Diseases Market Research Report 2024
Global Age Related Macular Degeneration Treatment Market Insights Forecast to 2030
Amblyopia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorders Treatment Market Research Report 2024
Global Leber s Hereditary Optic Neuropathy LHON Leber Optic Atrophy Market Insights Forecast to 2030
Global Inherited Retinal Disease Treatment Market Research Report 2024
Global Macular Degeneration Treatment Market Research Report 2024
Global Amyotrophic Lateral Sclerosis Therapeutics Market Insights Forecast to 2030
Global Amyotrophic Lateral Sclerosis ALS Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Q5936
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Acute Intermittent Porphyria Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6U7336
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Phenylketonuria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12R6229
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions